Dr Haidari obtained his Ph.D. in Biomedical Science in 2021 from the University of South Australia, where his research focused on synthesizing metallic nanoparticles for combating drug-resistant bacterial infections. His innovative approach led to the development of a smart hydrogel delivery system, revolutionizing localized therapies for chronic infections. As a researcher an active full time researcher at CMPH he continues to advance the frontiers of biomedical technology. His current research investigates novel antimicrobial agents and advanced wound healing therapies, utilizing nanotechnology to enhance treatment efficacy and patient outcomes. Driven by a commitment to translational research, he collaborates extensively across national and international levels, fostering partnerships that accelerate the development of next-generation therapeutics. 

Nanomedicine and biomaterials for antimicrobial and wound healing applications

Metallic nanoparticles (e.g., silver, cerium oxide, black phosphorus) for combating drug-resistant infections

Smart hydrogels and microneedles for localized drug delivery

Responsive wound dressings for pH and temperature-based monitoring

Biofilm disruption and treatment of chronic infected wounds, including diabetic ulcers

In vitro, ex vivo, and in vivo models for preclinical evaluation

Translational research integrating nanotechnology with clinical needs

Honours - 2 student 

Academia

• Future Industries Institue - University of South Australia 
• School of Animal and Veterinary Science - Adelaide University 
• RMIT University - Melbourne 
• CSIR - Institute of Minerals and Materials Technology - India
• Institute of Burn Research,Third Military Medical University (Army Medical University) - China

Industry

• Polynovo Pty Ltd
• Derby Rubber 
• CSIRO